The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 31, 2019
Filed:
Jun. 17, 2016
Applicant:
Sillajen, Inc., Busan, KR;
Inventors:
Tae Ho Hwang, Busan, KR;
Nam Hee Lee, Busan, KR;
Mong Cho, Busan, KR;
Ungbae Jeon, Busan, KR;
Doo Jin Byun, Daejeon, KR;
Assignee:
SILLAJEN, INC., Busan, KR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/768 (2015.01); C12N 7/00 (2006.01); A61K 9/00 (2006.01); A61K 47/42 (2017.01); A61K 38/19 (2006.01); A61K 35/763 (2015.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); A61K 9/0024 (2013.01); A61K 35/763 (2013.01); A61K 38/193 (2013.01); A61K 47/42 (2013.01); A61P 35/00 (2018.01); C12N 7/00 (2013.01); C12N 2710/24132 (2013.01); C12N 2710/24171 (2013.01);
Abstract
The present disclosure relates to oncolytic viruses for use transcatheter arterial viroembolization methods. The present disclosure also provides composition with such oncolytic viruses in combination with a biocompatible microparticle or hydrophilic polymer gel agent suitable for active embolization. The present disclosure further provides methods of transcatheter arterial viroembolization using such oncolytic viruses and compositions preferably in a manner that debulks tumor.